HOSPITAL UNIVERSITARIO RUBER
Departamento
Ohio State University Wexner Medical Center
Columbus, Estados UnidosPublicaciones en colaboración con investigadores/as de Ohio State University Wexner Medical Center (2)
2021
-
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Annals of Oncology, Vol. 32, Núm. 9, pp. 1148-1156
-
Sacituzumab govitecan in metastatic triple-negative breast cancer
New England Journal of Medicine, Vol. 384, Núm. 16, pp. 1529-1541